An experimental COVID-19 vaccine could potentially provide universal protection against future COVID-19 variants as well as other coronaviruses — maybe even the ones responsible for the common cold.

And it’s dirt cheap — less than $1 a dose, researchers say.

The vaccine targets a part of the COVID-19 virus’ spike protein that appears to be highly resistant to mutation and is common across nearly all coronaviruses, said senior researcher Dr. Steven Zeichner. He is a professor of pediatric infectious disease with the University of Virginia, in Charlottesville.